Immediate release tablet formulations: Formulation strategies, superdisintegrants, and evaluation parameters with special reference to antihypertensive drugs

Authors

  • Indrasen Chand Maurya Bhabha Pharmacy Research Institute-Bhopal-462026, M.P. Author
  • Shweta Shukla Bhabha Pharmacy Research Institute-Bhopal-462026, M.P. Author
  • Om Prakash Agrawal Bhabha Pharmacy Research Institute-Bhopal-462026, M.P. Author

Keywords:

Immediate release tablets, antihypertensive drugs, superdisintegrants, direct compression

Abstract

Immediate-release (IR) tablets represent the most widely utilized solid oral dosage forms owing to their simplicity, cost-effectiveness, and ability to provide rapid therapeutic action. In the management of cardiovascular disorders such as hypertension, prompt drug availability is often essential to achieve effective clinical outcomes. Antihypertensive agents, particularly β-adrenergic blockers, are commonly formulated as immediate-release dosage forms to ensure quick onset of action. Esmolol hydrochloride, a cardioselective β₁-blocker with rapid onset and short duration of action, serves as an ideal model drug for studying immediate-release formulation strategies. This review discusses the principles of immediate-release tablet formulation, selection of excipients with emphasis on superdisintegrants, manufacturing techniques, and evaluation parameters. The role of formulation variables in influencing disintegration and dissolution behavior is highlighted, along with recent advances in immediate-release tablet technology. The review aims to provide a comprehensive overview of formulation approaches for immediate-release tablets of antihypertensive drugs, supporting the development of effective and reliable oral dosage forms.

Downloads

Download data is not yet available.

Downloads

Published

19-12-2025

Issue

Section

Review Articles

How to Cite

1.
Maurya IC, Shukla S, Agrawal OP. Immediate release tablet formulations: Formulation strategies, superdisintegrants, and evaluation parameters with special reference to antihypertensive drugs. Int J of Adv in Sci Res [Internet]. 2025 Dec. 19 [cited 2026 Jan. 3];11(1):e5889. Available from: https://ssjournals.co.in/index.php/ijasr/article/view/5889